Q&A: FDA's Alberto Gutierrez Fields Questions on Evolving LDT, CDx Regulations | GenomeWeb
Home » Q&A: FDA's Alberto Gutierrez Fields Questions on Evolving LDT, CDx Regulations

Q&A: FDA's Alberto Gutierrez Fields Questions on Evolving LDT, CDx Regulations

Dec 30, 2014
|
Turna Ray
Premium

NEW YORK (GenomeWeb) – In October, the US Food and Drug Administration released draft guidances outlining its regulatory framework for laboratory-developed tests (LDTs).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Related Articles

Apr 21, 2015

FDA, CMS form Interagency Task Force to Coordinate LDT Regulation

Jun 17, 2015

Seeking Broader Support, House Committee Moves Dx Regulatory Proposal into Draft Legislation

Premium
Apr 17, 2015

Small Group of Labs, Dx Manufacturers Float Alternative to FDA LDT Guidance

Sep 28, 2015

Amid Competing LDT Regulatory Proposals, Common Ground but Key Disagreements for Congress to Consider

Premium
Feb 04, 2016

FDA to Finalize LDT Guidance Amid Uncertainty on Number of Genetic Tests Impacted

Nov 17, 2015

House E&C Committee Questions FDA, CMS About Scope of LDT Regulatory Problem

The Scan

This Week in Science

In Science this week: minimal bacterial genome of just 473 genes, and more.

Indiana Bans Abortions for Fetal Genetic Abnormalities

Indiana bans abortions because of fetal genetic abnormalities, the AP reports.

Support for Cancer Research

Americans largely support increasing funding for cancer research, according to a Stat News poll.

All About the Basics

In a letter in Science, the National Institutes of Health Director Francis Collins addresses concerns that the agency is moving away from basic research.

What's Popular?

In Molecular Diagnostics

  1. Foundation Medicine Shares Results From Validation of FoundationOne Heme in New Study

  2. Mother's Negligence Suit Against Quest's Athena Could Broadly Impact Genetic Testing Labs

  3. CareDx Q4 Revenues Fall 18 Percent

  4. Counsyl Finds Many Women Who Meet Cancer Screening Guidelines Not Getting Tested

    Premium

  5. CMS Contractors Issue Prices for Few MDx CPT Codes; Most Large Sequencing Panels Remain Unpriced

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.